126 related articles for article (PubMed ID: 3856614)
1. Kinetics of Ii synthesis, processing, and turnover in n-butyrate-treated Burkitt's lymphoma cell lines which express or do not express class II antigens and in hairy leukemic cells.
Spiro RC; Sairenji T; Humphreys RE
J Immunol; 1985 May; 134(5):3539-49. PubMed ID: 3856614
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Ii expression after n-butyrate treatment of a P3HR-1 Burkitt's lymphoma subline which does not express HLA-D.
Spiro RC; Sairenji T; Humphreys RE
Hematol Oncol; 1984; 2(3):239-47. PubMed ID: 6434395
[TBL] [Abstract][Full Text] [Related]
3. Structural analysis of invariant chain subsets as a function of their association with MHC class II chains.
Nguyen QV; Reyes VE; Humphreys RE
Arch Biochem Biophys; 1995 Feb; 317(1):128-32. PubMed ID: 7872774
[TBL] [Abstract][Full Text] [Related]
4. Ia antigens and associated invariant chain are induced simultaneously in lines of T-dependent mast cells by recombinant interferon-gamma.
Koch N; Wong GH; Schrader JW
J Immunol; 1984 Mar; 132(3):1361-9. PubMed ID: 6420464
[TBL] [Abstract][Full Text] [Related]
5. Differential Ia antigen expression by autologous human erythroid and B lymphoblastoid cell lines.
Symington FW; Levine F; Braun M; Brown SL; Erlich HA; Torok-Storb B
J Immunol; 1985 Aug; 135(2):1026-32. PubMed ID: 3874223
[TBL] [Abstract][Full Text] [Related]
6. Differential effect of TPA and n-butyrate on induction of Ii and EBV antigens in the P3HR-1 lymphoblastoid cell line.
Sairenji T; Spiro RC; Humphreys RE
Hematol Oncol; 1984; 2(4):381-9. PubMed ID: 6098544
[TBL] [Abstract][Full Text] [Related]
7. Murine Ia-associated invariant chain's processing to complex oligosaccharide forms and its dissociation from the I-Ak complex.
Holt GD; Swiedler SJ; Freed JH; Hart GW
J Immunol; 1985 Jul; 135(1):399-407. PubMed ID: 3873494
[TBL] [Abstract][Full Text] [Related]
8. Biochemical variation of human Ia like antigens detected with monoclonal antibodies.
Cohen BB; Deane DL; Van Heyningen V; Guy K; Hutchins D; Moxley M; Steel CM
Clin Exp Immunol; 1983 Jul; 53(1):41-50. PubMed ID: 6191895
[TBL] [Abstract][Full Text] [Related]
9. Antigen-dependent selection of B lymphoma cells varying in Ia density by cloned antigen-specific L3T4a+ T cells: a possible in vitro model for B cell adaptive differentiation.
Tite JP; Janeway CA
J Mol Cell Immunol; 1984; 1(4):253-65. PubMed ID: 6336593
[TBL] [Abstract][Full Text] [Related]
10. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
Geppert TD; Lipsky PE
J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
[TBL] [Abstract][Full Text] [Related]
11. Identification of hairy cell leukemia subset defining p35 as the human homologue of Ii.
Spiro RC; Sairenji T; Humphreys RE
Leuk Res; 1984; 8(1):55-62. PubMed ID: 6583461
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of sodium butyrate, dimethyl sulfoxide, and retinoic acid on membrane-associated antigen, enzymes, and glycoproteins of human rectal adenocarcinoma cells.
Tsao D; Morita A; Bella A; Luu P; Kim YS
Cancer Res; 1982 Mar; 42(3):1052-8. PubMed ID: 7059970
[TBL] [Abstract][Full Text] [Related]
13. B lymphoblast antigen (BB-1) expressed on Epstein-Barr virus-activated B cell blasts, B lymphoblastoid cell lines, and Burkitt's lymphomas.
Yokochi T; Holly RD; Clark EA
J Immunol; 1982 Feb; 128(2):823-7. PubMed ID: 6274961
[TBL] [Abstract][Full Text] [Related]
14. Requirement for protein synthesis in antigen processing by B cells.
Soreng KM; Moore JC; Sherman MA; Jensen PE
Cell Immunol; 1994 Aug; 157(1):277-90. PubMed ID: 8039248
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of the invariant chain in mouse tumor cells: relationship to B lymphoid development.
Koch N; Harris AW
J Immunol; 1984 Jan; 132(1):12-5. PubMed ID: 6418793
[TBL] [Abstract][Full Text] [Related]
16. HLA class-I and class-II antigen expression by human leukemic K562 cells and by Burkitt-K562 hybrids: modulation by differentiation inducers and interferon.
Garson D; Dokhélar MC; Wakasugi H; Mishal Z; Tursz T
Exp Hematol; 1985 Oct; 13(9):885-90. PubMed ID: 3930277
[TBL] [Abstract][Full Text] [Related]
17. Acquisition of peptides by MHC class II polypeptides in the absence of the invariant chain.
Hitzel C; van Endert P; Koch N
J Immunol; 1995 Feb; 154(3):1048-56. PubMed ID: 7822782
[TBL] [Abstract][Full Text] [Related]
18. Biosynthesis and glycosylation of the invariant chain associated with HLA-DR antigens.
Machamer CE; Cresswell P
J Immunol; 1982 Dec; 129(6):2564-9. PubMed ID: 6982931
[TBL] [Abstract][Full Text] [Related]
19. Surface expression of the invariant chain (CD74) is independent of concomitant expression of major histocompatibility complex class II antigens.
Henne C; Schwenk F; Koch N; Möller P
Immunology; 1995 Feb; 84(2):177-82. PubMed ID: 7750992
[TBL] [Abstract][Full Text] [Related]
20. Delivery of nascent MHC class II-invariant chain complexes to lysosomal compartments and proteolysis of invariant chain by cysteine proteases precedes peptide binding in B-lymphoblastoid cells.
Morton PA; Zacheis ML; Giacoletto KS; Manning JA; Schwartz BD
J Immunol; 1995 Jan; 154(1):137-50. PubMed ID: 7995933
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
